NCT04796363View on ClinicalTrials.gov

US Guided Erector Spinae Plane Block in Breast Cancer Surgery: Analgesia, Spread and Immunomodulation

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 25, 2020

Primary Completion Date

January 11, 2022

Study Completion Date

January 21, 2022

Conditions
AnalgesiaBreast Cancer
Interventions
PROCEDURE

Erector Spinae Plane Block with Bubivacaine

Erector Spinae Plane Block with Bubivacaine 0.25% or 0.125% before breast cancer surgery

PROCEDURE

Standard General Anaesthesia

Standard General Anaesthesia without ESPB

Trial Locations (1)

21561

Medical Research Institute, Alexandria University, Alexandria

All Listed Sponsors
lead

Alexandria University

OTHER

NCT04796363 - US Guided Erector Spinae Plane Block in Breast Cancer Surgery: Analgesia, Spread and Immunomodulation | Biotech Hunter | Biotech Hunter